Y Yamamura

Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.

Akihiro Ohnishi, Y Orita, Ryunosuke Okahara et al. · Journal of Clinical Investigation · 1993 · 155 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Blood Pressure +17

Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs

Motoko Naitoh, Hiromichi Suzuki, M Murakami et al. · American Journal of Physiology-Heart and Circulatory Physiology · 1994 · 137 citations

Hypertension, Heart Failure, Cardiovascular Pharmacology +18

NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese

Nobuyuki Hamajima, Keitaro Matsuo, Hiroji Iwata et al. · International Journal of Clinical Oncology · 2002 · 111 citations

Cancer Risk, Genetics, Quinone Oxidoreductase 1 +9

Sox2 expression in human stomach adenocarcinomas with gastric and gastric‐and‐intestinal‐mixed phenotypes

Tetsuya Tsukamoto, Tsutomu Mizoshita, M Mihara et al. · Histopathology · 2005 · 108 citations

ANGPTL4 is a secreted tumor suppressor that inhibits angiogenesis

Eriko Okochi‐Takada, Naoko Hattori, Tetsuya Tsukamoto et al. · Oncogene · 2013 · 90 citations

Angiogenesis, Vascular Biology, Tumor Suppressor +5